Zhou Fuxiang

Academic / Other · 5 registered clinical trials.

Status	Trial	Phase	Started
Unknown	Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary Stage IV Pancreatic Cancer, Hepatocellular Carcinoma , Cholangiocarcinoma	Phase 1	2022-02-07
Unknown	Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer Metastatic Colorectal Cancer	Phase 2	2021-07-22
Unknown	Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric Cance Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma	Phase 2	2021-05-14
Unknown	Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer Rectal Cancer	Phase 2	2021-03-08
Unknown	The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Meta Metastatic Gastric Cancer	Phase 2	2017-05-20